InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Marquet Magda. Director active across 3 companies, notably Arcturus Therapeutics Holdings Inc.. Aggregated, 9 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €83k. History available since 15 December 2022. The latest transaction was filed on 15 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Marquet Magda is a declarant linked to Immix Biopharma, Inc., Anaptysbio, INC and Arcturus Therapeutics Holdings Inc., where the listed role is Director. The declarant has 8 filings in total, and across the recent filings available, acquisitions total EUR 83077, with no sales, between 2022-12-19 and 2025-06-17.